Table 2 Case summary of complete remission (CR) of advanced hepatocellular carcinoma achieved by sorafenib treatment
From: Case analysis of complete remission of advanced hepatocellular carcinoma achieved with sorafenib
Case No. | Age (year), gender | Metastatic sites | Initial dose | CR time (month) | CR duration (month) | Publication time | Journal | Reference | Note |
|---|---|---|---|---|---|---|---|---|---|
1 | 78, male | Lung | 400 | 5 | 6 | 17/10/08 | Journal of Hematology & Oncology | So et al. [4] | First case of CR |
2 | 54, male | Lung | 400 | 18 | Unknown | 1/9/09 | American Journal of Transplantation | Yeganeh et al. [5] | Solitary pulmonary metastasis post liver transplantation |
3 | 59, male | Portal vein | 400 | 6 | 16 | 14/3/10 | Liver International ISSN | Irtan et al. [6] | Two cases reported in the same report; CR achieved by surgical resection in the descent stage following sorafenib treatment. |
4 | 57, male | Portal vein | 400 | 6 | 12 | 14/3/10 | Liver International ISSN | Irtan et al. [6] | |
5 | 74, male | Portal vein | 200 | 8 | 16 | 23/3/10 | Targeted Oncology | Wang et al. [7] | Initial dose at a low level |
6 | 67, male | Portal lymph node | 400 | 6 | 6 | 31/8/10 | Medical Oncology | Chelis et al. [8] | HIV-hepatitis B virus (HBV) co-infected with advanced hepatocellular carcinoma |
7 | 56, male | Thoracic diaphragm | 400 | 6 | 6 | 20/4/11 | Journal of Clinical Oncology | Curtit et al. [9] | CR achieved by surgical resection in the descent stage following sorafenib treatment. |
8 | 84, male | Portal vein | 400 | 6 | 6 | 11/4/11 | BMC Gastroenterology | Sacco et al. [10] | First case of CR in hepatitis C patients in older people |
9 | 76, female | Lung | 200 | 4 | 8 | 22/12/11 | Oncology | Inuzuka et al. [11] | First female case |
10 | 60, male | Portal lymph node | 400 | 11 days | 12 | 24/7/12 | Oncology | Mizukami et al. [12] | Shortest time to achieve CR |
11 | 52, male | Lung | 400 | 6 | 42 | 10/10/12 | Journal of Gastrointestinal Cancer | Lulla et al. [13] | Longest duration of CR |
12 | 66, male | Portal vein | 400 | 6 | 8 | 15/2/13 | World Journal of Gastrointestinal Oncology | Kim et al. [14] |